DiRaimondo Thomas bought JANX
January 2, 2024 · Form 4 insider transaction
DiRaimondo Thomas bought 147,000 shares of Janux Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
147,000
Price
$0.00
Total value
N/A
InsiderDiRaimondo Thomas
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 3, 2024
Shares owned after147,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option vest on January 1, 2025 and the balance will vest in equal monthly installments thereafter over a three year period.